An imported enteric fever caused by a quinolone-resistant Salmonella Typhi.

Annals of Saudi Medicine
Ali Mohammed Somily

Abstract

Recent reports indicate that nalidixic acid susceptibility correlates well with the clinical outcome of patients with Salmonella Typhi infection treated with quinolones. We report a case of enteric fever caused by S Typhi in which the isolate was resistant to nalidixic acid, but showed in vitro susceptibility to ciprofloxacin. Following treatment with ciprofloxacin, the clinical outcome was not satisfactory and the patient had a relapse. However, after using a higher dose of ciprofloxacin, the patient was cured. We recommend that all Salmonella systemic infections resistant to nalidixic acid with in vitro but decreased susceptibility to fluoroquinolones be treated with other antibiotics like third-generation cephalosporins or azithromycin. These patients should be closely followed up and observed for further relapse.

References

Jun 16, 1990·Lancet·L J PiddockR Wise
Aug 1, 1990·The Journal of Antimicrobial Chemotherapy·A J HowardB Rowe
Sep 1, 1990·Antimicrobial Agents and Chemotherapy·C S ToroG C Mora
Oct 1, 1989·Clinical Microbiology Reviews·J S Wolfson, D C Hooper
Jan 1, 1993·The American Journal of Tropical Medicine and Hygiene·P S RaoP G Shivananda
May 1, 1993·Antimicrobial Agents and Chemotherapy·A ForrestJ J Schentag
May 1, 1993·Antimicrobial Agents and Chemotherapy·P DuttaM Lahiri
Jul 1, 1997·Emerging Infectious Diseases·H HerikstadF J Angulo
Feb 7, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J WainC M Parry
Feb 10, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·W A Craig
Jun 11, 1998·Emerging Infectious Diseases·M D HamptonE J Threlfall
Jul 4, 1998·Lancet·D A MurdochN A Banatvala
May 20, 2000·JAMA : the Journal of the American Medical Association·M L AckersE D Mintz
Jun 1, 2001·Emerging Infectious Diseases·E J Threlfall, L R Ward
Dec 4, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Camilla RodriguesV R Joshi
Apr 12, 2002·Proceedings of the National Academy of Sciences of the United States of America·John H Tran, George A Jacoby
Apr 25, 2002·Emerging Infectious Diseases·Efrain M RibotTimothy J Barrett
May 15, 2002·FEMS Microbiology Reviews·Laura J V Piddock
Sep 11, 2002·Emerging Infectious Diseases·Roberto Docampo
Nov 29, 2002·The New England Journal of Medicine·Christopher M ParryJeremy J Farrar
Sep 8, 2005·Journal of Clinical Microbiology·Deborah HouseJeremy J Farrar
Oct 1, 1996·International Journal of Antimicrobial Agents·A M Kambal

❮ Previous
Next ❯

Methods Mentioned

BETA
electrophoresis

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Related Papers

The New England Journal of Medicine
Christopher M ParryJeremy Farrar
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
John A CrumpFrederick J Angulo
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
R CarnevaleFrank Møller Aarestrup
© 2021 Meta ULC. All rights reserved